Welltower Equity Method Investments decreased by 1.4% to $1.81B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.3%, from $1.77B to $1.81B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 13.8% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.02B | $977.96M | $1.04B | $1.14B | $1.30B | $1.38B | $1.50B | $1.60B | $1.65B | $1.57B | $1.64B | $1.72B | $1.71B | $1.74B | $1.77B | $1.79B | $1.96B | $1.84B | $1.81B |
| QoQ Change | — | -4.1% | +6.2% | +9.6% | +14.3% | +6.3% | +8.4% | +6.4% | +3.4% | -5.0% | +4.4% | +5.1% | -0.6% | +1.9% | +1.5% | +1.1% | +9.9% | -6.5% | -1.4% |
| YoY Change | — | — | — | — | +27.5% | +41.4% | +44.3% | +40.2% | +26.8% | +13.4% | +9.1% | +7.7% | +3.6% | +11.1% | +8.1% | +3.9% | +14.9% | +5.3% | +2.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.